Skrr Pharma Solutions Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
as on 26-07-2024
- Paid Up Capital ₹ 4.80 Cr
as on 26-07-2024
- Company Age 8 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Revenue %
(FY 2023)
- Profit -983.87%
(FY 2023)
- Ebitda -9305.86%
(FY 2023)
- Net Worth -12.18%
(FY 2023)
- Total Assets -12.06%
(FY 2023)
About Skrr Pharma Solutions
The Corporate was formerly known as Skrr Home Solutions Private Limited. The Company is engaged in the Real Estate And Construction Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 4.80 Cr, as per Ministry of Corporate Affairs (MCA) records.
Sanjiw Singh, Rana Kumar, Renu Singh, and One other member serve as directors at the Company.
- CIN/LLPIN
U70109HR2016PTC065365
- Company No.
065365
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Aug 2016
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Gurgaon, Haryana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Skrr Pharma Solutions?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sanjiw Singh  | Director | 10-Aug-2016 | Current |
| Rana Kumar | Director | 10-Aug-2016 | Current |
| Renu Singh | Director | 14-Oct-2016 | Current |
Financial Performance of Skrr Pharma Solutions.
Skrr Pharma Solutions Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 983.87% decrease in profit. The company's net worth observed a substantial decline by a decrease of 12.18%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Skrr Pharma Solutions?
In 2023, Skrr Pharma Solutions had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Protech Bio Systems Private LimitedActive 26 years 1 monthRana Kumar and Renu Singh are mutual person
- Protech Cold Storage Private LimitedActive 16 years 9 months
Sanjiw Singh and Rana Kumar are mutual person
- Alice Medicare Private LimitedActive 11 years 14 days
Sanjiw Singh, Rana Kumar and 1 more are mutual person
- Procare Pharma Private LimitedActive 10 years 11 months
Sanjiw Singh, Rana Kumar and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Skrr Pharma Solutions?
Unlock and access historical data on people associated with Skrr Pharma Solutions, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Skrr Pharma Solutions, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Skrr Pharma Solutions's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
